Skip to main content
Top
Published in: Calcified Tissue International 6/2015

01-06-2015 | Original Research

Adjusting Fracture Probability by Trabecular Bone Score

Authors: Eugene V. McCloskey, Anders Odén, Nicholas C. Harvey, William D. Leslie, Didier Hans, Helena Johansson, John A. Kanis

Published in: Calcified Tissue International | Issue 6/2015

Login to get access

Abstract

The aim of the present study was to determine the impact of trabecular bone score on the probability of fracture above that provided by the clinical risk factors utilized in FRAX. We performed a retrospective cohort study of 33,352 women aged 40–99 years from the province of Manitoba, Canada, with baseline measurements of lumbar spine trabecular bone score (TBS) and FRAX risk variables. The analysis was cohort-specific rather than based on the Canadian version of FRAX. The associations between trabecular bone score, the FRAX risk factors and the risk of fracture or death were examined using an extension of the Poisson regression model and used to calculate 10-year probabilities of fracture with and without TBS and to derive an algorithm to adjust fracture probability to take account of the independent contribution of TBS to fracture and mortality risk. During a mean follow-up of 4.7 years, 1754 women died and 1639 sustained one or more major osteoporotic fractures excluding hip fracture and 306 women sustained one or more hip fracture. When fully adjusted for FRAX risk variables, TBS remained a statistically significant predictor of major osteoporotic fractures excluding hip fracture (HR/SD 1.18, 95 % CI 1.12–1.24), death (HR/SD 1.20, 95 % CI 1.14–1.26) and hip fracture (HR/SD 1.23, 95 % CI 1.09–1.38). Models adjusting major osteoporotic fracture and hip fracture probability were derived, accounting for age and trabecular bone score with death considered as a competing event. Lumbar spine texture analysis using TBS is a risk factor for osteoporotic fracture and a risk factor for death. The predictive ability of TBS is independent of FRAX clinical risk factors and femoral neck BMD. Adjustment of fracture probability to take account of the independent contribution of TBS to fracture and mortality risk requires validation in independent cohorts.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129 World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129
2.
go back to reference Bala Y, Zebaze R, Ghasem-Zadeh A et al (2014) Cortical porosity identifies women with osteopenia at increased risk for forearm fractures. J Bone Miner Res 26:1356–1362CrossRef Bala Y, Zebaze R, Ghasem-Zadeh A et al (2014) Cortical porosity identifies women with osteopenia at increased risk for forearm fractures. J Bone Miner Res 26:1356–1362CrossRef
3.
go back to reference Diez-Perez A, Gonzalez-Macias J, Marin F et al (2007) Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int 18:629–639CrossRefPubMed Diez-Perez A, Gonzalez-Macias J, Marin F et al (2007) Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int 18:629–639CrossRefPubMed
4.
go back to reference Faulkner KG, Cummings SR, Black D, Palermo L, Gluer CC, Genant HK (1993) Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res 8:1211–1217CrossRefPubMed Faulkner KG, Cummings SR, Black D, Palermo L, Gluer CC, Genant HK (1993) Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res 8:1211–1217CrossRefPubMed
5.
6.
go back to reference Guerri-Fernandez RC, Nogues X, Quesada Gomez JM et al (2013) Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls. J Bone Miner Res 28:162–168CrossRefPubMed Guerri-Fernandez RC, Nogues X, Quesada Gomez JM et al (2013) Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls. J Bone Miner Res 28:162–168CrossRefPubMed
7.
go back to reference Yang L, Peel N, Clowes JA, McCloskey EV, Eastell R (2009) Use of DXA-based structural engineering models of the proximal femur to discriminate hip fracture. J Bone Miner Res 24:33–42CrossRefPubMedCentralPubMed Yang L, Peel N, Clowes JA, McCloskey EV, Eastell R (2009) Use of DXA-based structural engineering models of the proximal femur to discriminate hip fracture. J Bone Miner Res 24:33–42CrossRefPubMedCentralPubMed
9.
go back to reference Randall C, Bridges D, Guerri R et al (2013) Applications of a new handheld reference point indentation instrument measuring bone material strength. J Med Device 7:410051–410056CrossRefPubMed Randall C, Bridges D, Guerri R et al (2013) Applications of a new handheld reference point indentation instrument measuring bone material strength. J Med Device 7:410051–410056CrossRefPubMed
10.
go back to reference Silva BC, Leslie WD, Resch H et al (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530CrossRefPubMed Silva BC, Leslie WD, Resch H et al (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518–530CrossRefPubMed
11.
go back to reference Kanis JA on behalf of the World Health Organization Scientific Group. 2007 Assessment of osteoporosis at the primary health-care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK Kanis JA on behalf of the World Health Organization Scientific Group. 2007 Assessment of osteoporosis at the primary health-care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK
12.
go back to reference Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397CrossRefPubMedCentralPubMed Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397CrossRefPubMedCentralPubMed
13.
go back to reference Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV, Epidemiology and Quality of Life Working Group of IOF (2013) Worldwide uptake of FRAX. Arch Osteoporos 8:166CrossRef Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV, Epidemiology and Quality of Life Working Group of IOF (2013) Worldwide uptake of FRAX. Arch Osteoporos 8:166CrossRef
14.
go back to reference Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6:275–282CrossRefPubMed Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6:275–282CrossRefPubMed
15.
go back to reference Leslie WD, Caetano PA, Macwilliam LR, Finlayson GS (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25–30CrossRefPubMed Leslie WD, Caetano PA, Macwilliam LR, Finlayson GS (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25–30CrossRefPubMed
16.
go back to reference Leslie WD, Johansson H, Kanis JA et al (2014) Lumbar spine texture enhances ten-year fracture probability assessment. Osteoporos Int 25:2271–2277CrossRefPubMed Leslie WD, Johansson H, Kanis JA et al (2014) Lumbar spine texture enhances ten-year fracture probability assessment. Osteoporos Int 25:2271–2277CrossRefPubMed
17.
go back to reference Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res 27:1243–1251CrossRefPubMed Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res 27:1243–1251CrossRefPubMed
18.
go back to reference Leslie WD, Tsang JF, Caetano PA, Lix LM (2007) Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab 92:77–81CrossRefPubMed Leslie WD, Tsang JF, Caetano PA, Lix LM (2007) Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab 92:77–81CrossRefPubMed
19.
go back to reference Lix LM, Azimaee M, Osman BA et al (2012) Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 12:301CrossRefPubMedCentralPubMed Lix LM, Azimaee M, Osman BA et al (2012) Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 12:301CrossRefPubMedCentralPubMed
20.
go back to reference Looker AC, Wahner HW, Dunn WL et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–489CrossRefPubMed Looker AC, Wahner HW, Dunn WL et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–489CrossRefPubMed
21.
go back to reference Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769CrossRefPubMed Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769CrossRefPubMed
22.
go back to reference Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046CrossRefPubMed Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046CrossRefPubMed
23.
go back to reference Kanis JA, McCloskey EV, Johansson H, etal. 2008 Case finding for the management of osteoporosis with FRAX®—Assessment and intervention thresholds for the UK. Osteoporos Int 19: 1395–1408 Erratum 2009 Osteoporos Int 20, 499–502 Kanis JA, McCloskey EV, Johansson H, etal. 2008 Case finding for the management of osteoporosis with FRAX®—Assessment and intervention thresholds for the UK. Osteoporos Int 19: 1395–1408 Erratum 2009 Osteoporos Int 20, 499–502
24.
go back to reference Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int 22:839–847CrossRefPubMed Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int 22:839–847CrossRefPubMed
25.
go back to reference Johansson H, Kanis JA, Odén A et al (2014) Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts. Calcif Tissue Int 95:428–435CrossRefPubMed Johansson H, Kanis JA, Odén A et al (2014) Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts. Calcif Tissue Int 95:428–435CrossRefPubMed
26.
go back to reference Kanis JA, Johansson H, Oden A, McCloskey EV (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22:809–816CrossRefPubMed Kanis JA, Johansson H, Oden A, McCloskey EV (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22:809–816CrossRefPubMed
28.
go back to reference Leslie WD, Lix LM, Johansson H et al (2010) Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 25:2350–2358CrossRefPubMed Leslie WD, Lix LM, Johansson H et al (2010) Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 25:2350–2358CrossRefPubMed
29.
go back to reference Krieg MA, Aubry-Rozier B, Hans D et al (2013) Effects of antiresorptive agents on trabecular bone score (TBS) in older women. Osteoporos Int 24:1073–1078CrossRefPubMed Krieg MA, Aubry-Rozier B, Hans D et al (2013) Effects of antiresorptive agents on trabecular bone score (TBS) in older women. Osteoporos Int 24:1073–1078CrossRefPubMed
30.
go back to reference Popp AW, Guler S, Lamy O et al (2013) Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study. J Bone Miner Res 28:449–454CrossRefPubMed Popp AW, Guler S, Lamy O et al (2013) Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study. J Bone Miner Res 28:449–454CrossRefPubMed
Metadata
Title
Adjusting Fracture Probability by Trabecular Bone Score
Authors
Eugene V. McCloskey
Anders Odén
Nicholas C. Harvey
William D. Leslie
Didier Hans
Helena Johansson
John A. Kanis
Publication date
01-06-2015
Publisher
Springer US
Published in
Calcified Tissue International / Issue 6/2015
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-9980-x

Other articles of this Issue 6/2015

Calcified Tissue International 6/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.